1
Wang XQ, Pu DL, Leng WL, Lei XT, Juan J, La Z, Yao D, Xi JZ, Jian L, Miao T, Wu QN. Efficacy of Huangma Ding or autologous platelet-rich gel for the diabetic lower extremity arterial disease patients with foot ulcers. World J Diabetes 2024; 15(5): 923-934
2
Emad-Eldin M, Balata GF, Elshorbagy EA, Hamed MS, Attia MS. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges. World J Diabetes 2024; 15(5): 828-852
3
Zhang Y, Li T, Yue CY, Liu Y. Associations of serum D-dimer and glycosylated hemoglobin levels with third-trimester fetal growth restriction in gestational diabetes mellitus. World J Diabetes 2024; 15(5): 914-922
4
Wan XH, Jin GB, Yang Q, Hu JL, Liu ZL, Rao J, Wen C, Li PL, Yang XM, Huang B, Wang XZ. Novel miR-490-3p/hnRNPA1-b/PKM2 axis mediates the Warburg effect and proliferation of colon cancer cells via the PI3K/AKT pathway. World J Gastrointest Oncol 2024; 16(5): 2038-2059
5
Peng WB, Li YP, Zeng Y, Chen K. Transglutaminase 2 serves as a pathogenic hub gene of KRAS mutant colon cancer based on integrated analysis. World J Gastrointest Oncol 2024; 16(5): 2074-2090
6
La Grasta Sabolic L, Marusic S, Cigrovski Berkovic M. Challenges and pitfalls of youth-onset type 2 diabetes. World J Diabetes 2024; 15(5): 876-885
7
Al-Bari MAA, Peake N, Eid N. Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges. World J Diabetes 2024; 15(5): 853-866
8
Xue JJ, Hu ST, Wang CC, Chen ZC, Cheng SY, Yu SQ, Peng HJ, Zhang YT, Zeng WJ. Prognostic relevance of ventricular arrhythmias in surgical patients with gastrointestinal tumors. World J Gastrointest Oncol 2024; 16(5): 1787-1795
9
Ye YX, Yang L, Kang Z, Wang MQ, Xie XD, Lou KX, Bao J, Du M, Li ZX. Magnetic resonance imaging-based lymph node radiomics for predicting the metastasis of evaluable lymph nodes in rectal cancer. World J Gastrointest Oncol 2024; 16(5): 1849-1860
10
Bai HX, Qiu XM, Xu CH, Guo JQ. MiRNA-145-5p inhibits gastric cancer progression via the serpin family E member 1- extracellular signal-regulated kinase-1/2 axis. World J Gastrointest Oncol 2024; 16(5): 2123-2140
11
Zhu XL, Zhang L, Qi SX. Association of complement components with risk of colorectal cancer: A systematic review and meta-analysis. World J Gastrointest Oncol 2024; 16(5): 2168-2180
12
Kong LS, Tao R, Li YF, Wang WB, Zhao X. METTL5 promotes cell proliferation, invasion, and migration by up-regulating Toll-like receptor 8 expression in colorectal cancer. World J Gastrointest Oncol 2024; 16(5): 2006-2017
13
Lu DD, Yuan L, Wang ZZ, Zhao JJ, Du YH, Ning N, Chen GQ, Huang SC, Yang Y, Zhang Z, Nan Y. To explore the mechanism of Yigong San anti-gastric cancer and immune regulation. World J Gastrointest Oncol 2024; 16(5): 1965-1994
14
Wang L, Gong WH. Predictive model using four ferroptosis-related genes accurately predicts gastric cancer prognosis. World J Gastrointest Oncol 2024; 16(5): 2018-2037
15
Wang JF, Yang XX, Zhang J, Zheng Y, Zhang FQ, Shi XF, Wang YL. Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19. World J Gastrointest Oncol 2024; 16(5): 2113-2122
16
Zhang YQ, Li J, Qin Z, Li DM, Ye FZ, Bei SH, Zhang XH, Feng L. METTL5 promotes gastric cancer progression via sphingomyelin metabolism. World J Gastrointest Oncol 2024; 16(5): 1925-1946
17
Sánchez-Ramírez D, Mendoza-Rodríguez MG, Alemán OR, Candanedo-González FA, Rodríguez-Sosa M, Montesinos-Montesinos JJ, Salcedo M, Brito-Toledo I, Vaca-Paniagua F, Terrazas LI. Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression. World J Gastrointest Oncol 2024; 16(5): 1705-1724
18
Liu B, Zhang ZX, Nie XY, Sun WL, Yan YJ, Fu WH. Clinical outcome and prognostic factors of T4N0M0 colon cancer after R0 resection: A retrospective study. World J Gastrointest Oncol 2024; 16(5): 1869-1877
19
Fazal F, Khan MA, Shawana S, Rashid R, Mubarak M. Correlation of tumor-associated macrophage density and proportion of M2 subtypes with the pathological stage of colorectal cancer. World J Gastrointest Oncol 2024; 16(5): 1878-1889
20
Rozani S, Lykoudis PM. Overcoming geographical and socioeconomic limitations in colorectal cancer screening. World J Gastrointest Oncol 2024; 16(5): 1683-1689